Skip to content
  • Tuesday, 17 November 2026
  • 8:57 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Amberstone, Henlius agree to develop solid-tumour T-cell engagers
Pharmaceutical R&D

Amberstone, Henlius agree to develop solid-tumour T-cell engagers

Teuku Ryan Sep 27, 2026 0

Biotechnology innovation continues to push the boundaries of oncology as companies seek safer and more effective ways to harness the…

Read More
Beyond the Singularity: How the Birth of Mini Universes Could Redefine Our Understanding of Black Holes and GravastarsCan live cell dynamics fix drug discovery’s efficacy problem?Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billionTWiV 1288: Clinical update with Dr. Daniel Griffin
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring SystemThe oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
YOU MAY HAVE MISSED
Neuroscience & Brain Research
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring System
Rifan Muazin Nov 5, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ